Abstract
Befloxatone is a competitive and reversible inhibitor of monoamine oxidase-A (MAOI-A). The aim of the study was to characterize the in vivo properties of [11C]befloxatone and to validate its use as a ligand for the study of MAO-A by positron emission tomography (PET). PET studies were performed in baboons after i.v. injection of [11C]befloxatone (551 ± 70 MBq, i.e.14.9 ± 1.9 mCi). [11C]Befloxatone enters rapidly in the brain with a maximum uptake at 30 min. Brain concentration of the tracer is high in thalamus, striatum, pons and cortical structures (1.5–1.8% of injected dose per 100 ml of tissue), and lower in cerebellum (1.07% injected dose/100 ml). Nonsaturable uptake, obtained after a pretreatment with a high dose of nonlabeled befloxatone (0.4 mg/kg), is very low and represents only 3% of the total uptake. Brain uptake of [11C]befloxatone is not altered by a pretreatment of a high dose with lazabemide (0.5 mg/kg i.v.), a selective MAOI-B but is completely blocked by a pretreatment with moclobemide (MAOI-A; 10 mg/kg). This confirms, in vivo, the selectivity of befloxatone for type A MAO. [11C]Befloxatone brain radioactivity was displaced by administration of unlabeled befloxatone (30 min after the tracer injection). The displacement of the tracer from its binding sites is dose-dependent, with an ID50 of 0.02 mg/kg for all studied structures. These results indicate that [11C]befloxatone will be an excellent probe for the study of MAO-A in humans using PET.
Footnotes
-
DOI: 10.1124/jpet.102.046953
- Abbreviations:
- MAO
- monoamine oxidase
- PET
- positron emission tomography
- HPLC
- high-performance liquid chromatography
- MRI
- magnetic resonance imaging
- TAC
- time activity curve
- ROI
- region of interest
- DV
- distribution volume
- ID
- injected dose
- AUC
- area under the curve
- Received November 14, 2002.
- Accepted February 5, 2003.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|